| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACADIA PHARMACEUTICALS INC COM | 1,486,460 | 42,870,000 | 8.66% | ||
| 2 | IMMUNOMEDICS INC | 9,263,340 | 33,996,000 | 6.87% | ||
| 3 | BIOMARIN | 400,000 | 33,136,000 | 6.69% | ||
| 4 | Lion Biotechnologies | 4,520,643 | 31,418,000 | 6.35% | ||
| 5 | TESARO INC | 231,700 | 31,159,000 | 6.29% | ||
| 6 | SAREPTA THERAPEUTICS INC | 1,010,300 | 27,713,000 | 5.60% | ||
| 7 | NEURODERM LTD | 1,056,303 | 23,450,000 | 4.74% | ||
| 8 | DERMIRA INC | 765,709 | 23,224,000 | 4.69% | ||
| 9 | AERIE PHARMACEUTICALS INC | 610,000 | 23,089,000 | 4.66% | ||
| 10 | NEUROCRINE BIOSCIE COM USD0.001 | 541,000 | 20,937,000 | 4.23% | ||
| 11 | ALEXION PHARMACEUTIC | 170,000 | 20,800,000 | 4.20% | ||
| 12 | AMICUS THERAPEUTICS INC | 4,017,577 | 19,967,000 | 4.03% | ||
| 13 | BRISTOL MYERS SQUIBB CO | 285,000 | 16,655,000 | 3.36% | ||
| 14 | SEATTLE GENETICS INC | 295,533 | 15,595,000 | 3.15% | ||
| 15 | AGENUS INC | 3,750,430 | 15,452,000 | 3.12% | ||
| 16 | GLOBAL BLOOD THERAPEUTICS IN COM | 995,838 | 14,390,000 | 2.91% | ||
| 17 | Ascendis Pharma | 545,203 | 11,035,000 | 2.23% | ||
| 18 | TELIGENT INC NEW | 1,663,619 | 10,997,000 | 2.22% | ||
| 19 | BIOCRYST PHARMACEUTICALS | 1,631,502 | 10,327,000 | 2.09% | ||
| 20 | AKEBIA THERAPEUTICS INC | 831,515 | 8,656,000 | 1.75% | ||
| 21 | MIRATI THERAPEUTICS INC COM | 1,508,201 | 7,164,000 | 1.45% | ||
| 22 | SORRENTO THERAPEUTICS INC COM NEW | 1,456,056 | 7,135,000 | 1.44% | ||
| 23 | VERACYTE INC | 906,999 | 7,020,000 | 1.42% | ||
| 24 | VANDA PHARMACEUTICALS INC COM | 381,466 | 6,084,000 | 1.23% | ||
| 25 | ALIMERA SCIENCES INC | 4,034,488 | 4,357,000 | 0.88% | ||
| 26 | CASCADIAN THERAPEUTICS | 921,248 | 3,971,000 | 0.80% | ||
| 27 | XENCOR INC COM | 125,000 | 3,290,000 | 0.66% | ||
| 28 | ASSEMBLY BIOSCIENCES INC | 270,289 | 3,284,000 | 0.66% | ||
| 29 | FORTRESS BIOTECH INC | 1,200,342 | 3,241,000 | 0.65% | ||
| 30 | CORVUS PHARMACEUTICALS INC COM | 216,619 | 3,098,000 | 0.63% | ||
| 31 | ONCOBIOLOGICS INC | 683,531 | 2,057,000 | 0.42% | ||
| 32 | CELLECTIS S A | 97,096 | 1,646,000 | 0.33% | ||
| 33 | PERNIX THERAPEUTICS HOLDINGS INC | 6,000,000 | 1,479,000 | 0.30% | PRN | |
| 34 | ARRAY BIOPHARMA INC COM | 160,000 | 1,406,000 | 0.28% | ||
| 35 | TRILLIUM THERAPEUTICS INC | 227,399 | 1,285,000 | 0.26% | ||
| 36 | CATALYST PHARMACEUTICALS INC | 1,141,149 | 1,198,000 | 0.24% | ||
| 37 | BioDelivery Sciences International Inc | 644,176 | 1,127,000 | 0.23% | ||
| 38 | SAREPTA THERAPEUTICS INC | 150,000 | 615,000 | 0.12% | Put | |
| 39 | ACADIA PHARMACEUTICALS INC COM | 200,000 | 413,000 | 0.08% | Call | |
| 40 | ONCOBIOLOGICS INC - WARRANT B | 233,333 | 184,000 | 0.04% | ||
| 41 | ONCOBIOLOGICS INC - WARRANT A | 233,333 | 44,000 | 0.01% | ||
| 42 | AGENUS INC | 1,000,000 | 25,000 | 0.01% | Call | |
| 43 | IMMUNOMEDICS INC | 300,800 | 23,000 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-17-008458, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
